BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32939629)

  • 21. Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET.
    Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
    Ann Thorac Surg; 2021 Jul; 112(1):264-270. PubMed ID: 33058828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The surgical outcomes of lung cancer combined with interstitial pneumonia: a single-institution report.
    Taniguchi D; Yamasaki N; Miyazaki T; Tsuchiya T; Matsumoto K; Hatachi G; Kakugawa T; Sakamoto N; Mukae H; Nagayasu T
    Surg Today; 2017 Nov; 47(11):1397-1404. PubMed ID: 28589262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
    Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
    Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prediction of outcome after acute exacerbation of idiopathic interstitial pneumonia].
    Tsukamoto K; Chida K; Hayakawa H; Sato A; Nakajima Y; Doi O; Yamaguchi T; Taguchi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jul; 35(7):746-54. PubMed ID: 9341279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of partial pressure of arterial oxygen and radiologic findings on postoperative acute exacerbation of idiopathic interstitial pneumonia in patients with lung cancer.
    Azuma Y; Sakamoto S; Homma S; Sakai T; Koezuka S; Kamemura M; Tochigi N; Iyoda A
    Surg Today; 2024 Feb; 54(2):122-129. PubMed ID: 37278878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and subacute idiopathic interstitial pneumonias.
    Taniguchi H; Kondoh Y
    Respirology; 2016 Jul; 21(5):810-20. PubMed ID: 27123874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia.
    Homma S; Sakamoto S; Kawabata M; Kishi K; Tsuboi E; Motoi N; Yoshimura K
    Intern Med; 2005 Nov; 44(11):1144-50. PubMed ID: 16357451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative respiratory failure caused by acute exacerbation of idiopathic interstitial pneumonia.
    Kubota T; Miyata A
    J Anesth; 2011 Jun; 25(3):422-5. PubMed ID: 21487668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
    Ishikawa G; Acquah SO; Salvatore M; Padilla ML
    Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy.
    Sasano H; Hagiwara E; Kitamura H; Enomoto Y; Matsuo N; Baba T; Iso S; Okudela K; Iwasawa T; Sato S; Suzuki Y; Takemura T; Ogura T
    BMC Pulm Med; 2016 Dec; 16(1):168. PubMed ID: 27903248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct hemoperfusion with polymyxin B-immobilized fibre treatment for acute exacerbation of interstitial pneumonia.
    Furusawa H; Sugiura M; Mitaka C; Inase N
    Respirology; 2017 Oct; 22(7):1357-1362. PubMed ID: 28440556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of acute exacerbation of interstitial pneumonia in operated lung cancer: institutional report and review.
    Chida M; Kobayashi S; Karube Y; Hayama M; Tamura M; Ishihama H; Oyaizu T
    Ann Thorac Cardiovasc Surg; 2012; 18(4):314-7. PubMed ID: 22446955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia.
    Ushiki A; Yamazaki Y; Hama M; Yasuo M; Hanaoka M; Kubo K
    Respir Investig; 2014 Jan; 52(1):65-70. PubMed ID: 24388373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases.
    Kimura T; Nojiri T; Hosoda H; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
    Eur J Cardiothorac Surg; 2015 Oct; 48(4):e85-91. PubMed ID: 26224340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Pneumonia Resembling an Acute Exacerbation of Interstitial Pneumonia.
    Kitayama T; Kitamura H; Hagiwara E; Higa K; Okabayashi H; Oda T; Baba T; Komatsu S; Iwasawa T; Ogura T
    Intern Med; 2020 Dec; 59(24):3207-3211. PubMed ID: 33087668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
    Shirasawa M; Fukui T; Kusuhara S; Hiyoshi Y; Nakahara Y; Nishinarita N; Igawa S; Naoki K
    BMC Cancer; 2019 Feb; 19(1):163. PubMed ID: 30808322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
    Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
    Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience.
    Kawamura K; Ichikado K; Ichiyasu H; Anan K; Yasuda Y; Suga M; Sakagami T
    BMC Pulm Med; 2019 Jun; 19(1):113. PubMed ID: 31238929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung Cancer.
    Ito N; Masuda T; Nakashima T; Nakao S; Yamaguchi K; Sakamoto S; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Anticancer Res; 2021 Mar; 41(3):1497-1506. PubMed ID: 33788742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.